BCYC Reports Encouraging Initial Duravelo-2 Data: 65% ORR, 58% Confirmed ORR, Lower Toxicity vs SOC in Metastatic Urothelial Cancer Trial
Bicycle Therapeutics plc American Depositary Shares · PHARMACEUTICAL PREPARATIONS · Now $4.53
+2.7% in 3d after detection
Post-detection moves
1h
—
1d
+2.2%
3d
+2.7%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS